Evidence map›Paper›PMID 41114175›Full record

ArticleACS omega2025

Quantitative Lateral Flow Assay for Meropenem Determination: A Proof-of-Concept Study.

Vasin Vasikasin, Alaa Riezk, Richard C Wilson, Timothy M Rawson, Anthony E G Cass, Alison H Holmes

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vasin VasikasinCentre for Antimicrobial Optimisation, Imperial College London, London SW7 2AZ, U.K.ORCID https://orcid.org/0000-0002-1761-0978
Alaa RiezkCentre for Antimicrobial Optimisation, Imperial College London, London SW7 2AZ, U.K.
Richard C WilsonCentre for Antimicrobial Optimisation, Imperial College London, London SW7 2AZ, U.K.ORCID https://orcid.org/0000-0002-3275-6932
Timothy M RawsonCentre for Antimicrobial Optimisation, Imperial College London, London SW7 2AZ, U.K.
Anthony E G CassCentre for Antimicrobial Optimisation, Imperial College London, London SW7 2AZ, U.K.ORCID https://orcid.org/0000-0001-8881-4786
Alison H HolmesCentre for Antimicrobial Optimisation, Imperial College London, London SW7 2AZ, U.K.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Therapeutic drug monitoring (TDM) is essential for optimizing antibiotic dosing, particularly in critically ill patients. However, conventional methods, such as LC/MS, have long turnaround times, limiting timely dose adjustment. We developed a novel competitive lateral flow assay (LFA) format with dual test lines previously validated for vancomycin and adapted it for Meropenem quantification. Using BlaR-CTD, a beta-lactam receptor protein, in place of an antibody and biotinylated BSA-Meropenem conjugated to gold nanoparticles, the LFA produced a concentration-dependent change in test line intensities. A custom image analysis algorithm showed strong correlation with Meropenem concentrations (

Identifiers

PMID41114175
PMCPMC12529179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.